MX2017009351A - Metodo y sistema para determinar el estado de cancer. - Google Patents
Metodo y sistema para determinar el estado de cancer.Info
- Publication number
- MX2017009351A MX2017009351A MX2017009351A MX2017009351A MX2017009351A MX 2017009351 A MX2017009351 A MX 2017009351A MX 2017009351 A MX2017009351 A MX 2017009351A MX 2017009351 A MX2017009351 A MX 2017009351A MX 2017009351 A MX2017009351 A MX 2017009351A
- Authority
- MX
- Mexico
- Prior art keywords
- cancer status
- determining cancer
- platforms
- systems
- readable medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Genetics & Genomics (AREA)
- Data Mining & Analysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
En la presente invención se divulgan métodos, sistemas, plataformas, un medio no transitorio legible por computadora, servicios y equipos para determinar un tipo de cáncer en un individuo. También se describen aquí métodos, sistemas, plataformas, un medio no transitorio legible por computadora, y composiciones para generar una base de datos de perfiles de metilación de CpG.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562104785P | 2015-01-18 | 2015-01-18 | |
US14/986,520 US9984201B2 (en) | 2015-01-18 | 2015-12-31 | Method and system for determining cancer status |
PCT/US2016/013716 WO2016115530A1 (en) | 2015-01-18 | 2016-01-15 | Method and system for determining cancer status |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017009351A true MX2017009351A (es) | 2017-10-24 |
Family
ID=56406499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017009351A MX2017009351A (es) | 2015-01-18 | 2016-01-15 | Metodo y sistema para determinar el estado de cancer. |
Country Status (15)
Country | Link |
---|---|
US (2) | US9984201B2 (es) |
EP (1) | EP3245604B1 (es) |
JP (3) | JP2018508228A (es) |
KR (1) | KR20170120595A (es) |
CN (2) | CN108064314B (es) |
AU (1) | AU2016206505B2 (es) |
BR (1) | BR112017015413A2 (es) |
CA (1) | CA2974097A1 (es) |
EA (1) | EA036566B1 (es) |
HK (1) | HK1248285A1 (es) |
IL (1) | IL253546A0 (es) |
MX (1) | MX2017009351A (es) |
SG (2) | SG11201705878VA (es) |
TW (2) | TW201638815A (es) |
WO (1) | WO2016115530A1 (es) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3158085B1 (en) | 2014-06-18 | 2020-12-02 | Clear Gene, Inc. | Methods for rapid analysis of biological markers |
ES2741400T3 (es) | 2014-07-18 | 2020-02-10 | Univ Hong Kong Chinese | Análisis de patrones de metilación de tejidos en mezcla de ADN |
US9984201B2 (en) * | 2015-01-18 | 2018-05-29 | Youhealth Biotech, Limited | Method and system for determining cancer status |
CA3008273A1 (en) | 2015-12-18 | 2017-06-22 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
JP2019521673A (ja) * | 2016-06-07 | 2019-08-08 | ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア | 疾患および状態の分析のためのセルフリーdnaメチル化パターン |
CN109906275B (zh) | 2016-06-08 | 2023-05-12 | 爱荷华大学研究基金会 | 检测心血管疾病易感性的组合物和方法 |
US10093986B2 (en) | 2016-07-06 | 2018-10-09 | Youhealth Biotech, Limited | Leukemia methylation markers and uses thereof |
EP3481403B1 (en) | 2016-07-06 | 2022-02-09 | Youhealth Biotech, Limited | Solid tumor methylation markers and uses thereof |
CN109906276A (zh) * | 2016-11-07 | 2019-06-18 | 格里尔公司 | 用于检测早期癌症中体细胞突变特征的识别方法 |
AU2017369018B2 (en) | 2016-11-30 | 2021-02-25 | The Chinese University Of Hong Kong | Analysis of cell-free DNA in urine and other samples |
JP7300989B2 (ja) | 2016-12-22 | 2023-06-30 | ガーダント ヘルス, インコーポレイテッド | 核酸分子を解析するための方法およびシステム |
CN106544341A (zh) * | 2017-01-17 | 2017-03-29 | 上海亿康医学检验所有限公司 | 高效检测样本中的ctDNA的方法 |
BR112019018272A2 (pt) * | 2017-03-02 | 2020-07-28 | Youhealth Oncotech, Limited | marcadores metilação para diagnosticar hepatocelular carcinoma e câncer |
CN110770354B (zh) | 2017-04-19 | 2024-03-19 | 鹍远基因公司 | 用于文库构建和序列分析的组合物和方法 |
CA3060553A1 (en) * | 2017-04-19 | 2018-10-25 | Singlera Genomics, Inc. | Compositions and methods for detection of genomic variance and dna methylation status |
WO2018209361A2 (en) * | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Universal early cancer diagnostics |
CN111094590A (zh) * | 2017-07-12 | 2020-05-01 | 大学健康网络 | 使用甲基化组分析进行癌症检测和分类 |
WO2019055829A1 (en) | 2017-09-15 | 2019-03-21 | Nazarian Javad | METHODS OF DETECTION OF CANCER BIOMARKERS |
CA3076386A1 (en) * | 2017-09-29 | 2019-04-04 | Lukas Vrba | Dna methylation biomarkers for cancer diagnosing |
BR112020006912A2 (pt) * | 2017-10-06 | 2020-12-22 | Youhealth Oncotech, Limited | Marcadores de metilação para diagnóstico de câncer |
US10748040B2 (en) * | 2017-11-20 | 2020-08-18 | Kavya Venkata Kota Sai KOPPARAPU | System and method for automatic assessment of cancer |
JP2021503922A (ja) | 2017-11-28 | 2021-02-15 | グレイル, インコーポレイテッドGrail, Inc. | ターゲットシーケンシングのためのモデル |
WO2019157214A2 (en) * | 2018-02-07 | 2019-08-15 | Ai Technologies Inc. | Deep learning-based diagnosis and referral of diseases and disorders |
EP3765637A1 (en) * | 2018-03-13 | 2021-01-20 | Grail, Inc. | Anomalous fragment detection and classification |
US20190316209A1 (en) * | 2018-04-13 | 2019-10-17 | Grail, Inc. | Multi-Assay Prediction Model for Cancer Detection |
EP3802830A4 (en) * | 2018-05-31 | 2022-03-09 | The Regents of the University of California, A California Corporation | DNA METHYLATION-BASED BIOMARKERS OF IRRITABLE BOWEL SYNDROME AND IRRITABLE BOWEL DISEASE |
TW202410055A (zh) | 2018-06-01 | 2024-03-01 | 美商格瑞爾有限責任公司 | 用於資料分類之卷積神經網路系統及方法 |
CN108866192B (zh) * | 2018-07-26 | 2021-06-22 | 上海奕谱生物科技有限公司 | 基于甲基化修饰的肿瘤标记物stamp-ep1 |
CN110791563B (zh) * | 2018-08-01 | 2024-02-09 | 立森印迹诊断技术(无锡)有限公司 | 一种用于检测甲状腺肿瘤良恶性程度的分级模型及其应用 |
CN109022556A (zh) * | 2018-08-29 | 2018-12-18 | 天津智鱼生物科技有限公司 | 一种dna甲基化程度的定量方法及应用 |
US20210174968A1 (en) * | 2018-09-04 | 2021-06-10 | 3M Innovative Properties Company | Visualization of Social Determinants of Health |
EP3856903A4 (en) | 2018-09-27 | 2022-07-27 | Grail, LLC | METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL |
CN110265087A (zh) * | 2018-10-05 | 2019-09-20 | 中国医药大学附设医院 | 染色体异常检测模型、其检测系统及染色体异常检测方法 |
CN109182526A (zh) * | 2018-10-10 | 2019-01-11 | 杭州翱锐生物科技有限公司 | 用于早期肝癌辅助诊断的试剂盒及其检测方法 |
SG11202104882WA (en) * | 2018-11-15 | 2021-06-29 | Ampel Biosolutions Llc | Machine learning disease prediction and treatment prioritization |
GB201819452D0 (en) * | 2018-11-29 | 2019-01-16 | Ucl Business Plc | Differential methylation |
CA3119328A1 (en) * | 2018-12-19 | 2020-06-25 | Grail, Inc. | Cancer tissue source of origin prediction with multi-tier analysis of small variants in cell-free dna samples |
WO2020132544A1 (en) * | 2018-12-21 | 2020-06-25 | Grail, Inc. | Anomalous fragment detection and classification |
KR102211240B1 (ko) * | 2018-12-28 | 2021-02-01 | 아주대학교산학협력단 | 허혈성 심장질환에 대한 보조 의사 시스템에 의해 수행되는 허혈성 심장질환 진단 방법 |
KR102068310B1 (ko) * | 2019-02-28 | 2020-01-20 | 주식회사 레피다인 | 간암 재발 예측용 dna 메틸화 마커 및 이의 용도 |
WO2020179646A1 (ja) * | 2019-03-01 | 2020-09-10 | 国立大学法人佐賀大学 | 成人t細胞白血病/リンパ腫の検出方法 |
EP3948872A4 (en) * | 2019-03-28 | 2023-04-26 | Phase Genomics Inc. | SEQUENCING KARYOTYPING SYSTEMS AND METHODS |
US11773450B2 (en) | 2019-04-03 | 2023-10-03 | Grail, Llc | Methylation-based false positive duplicate marking reduction |
CN110157804A (zh) * | 2019-04-04 | 2019-08-23 | 广州优泽生物技术有限公司 | 用于肺癌诊断、疗效预测或预后的甲基化位点、检测引物及试剂盒 |
US12009061B2 (en) | 2019-04-10 | 2024-06-11 | University of Pittsburgh—of the Commonwealth System of Higher Education | Computational filtering of methylated sequence data for predictive modeling |
CN110163102A (zh) * | 2019-04-18 | 2019-08-23 | 麦克奥迪(厦门)医疗诊断系统有限公司 | 一种基于卷积神经网络的宫颈细胞图像分类识别方法 |
US20220220551A1 (en) * | 2019-04-22 | 2022-07-14 | Behavioral Diagnostics, Llc | Compositions and methods for correcting for cellular admixture in epigenetic analyses |
WO2020219721A1 (en) * | 2019-04-23 | 2020-10-29 | The Broad Institute, Inc. | Compositions and methods characterizing metastasis |
AU2020274348A1 (en) * | 2019-05-13 | 2021-12-09 | Grail, Llc | Model-based featurization and classification |
CN111204867B (zh) * | 2019-06-24 | 2021-12-10 | 北京工业大学 | 膜生物反应器-mbr膜污染智能决策方法 |
TWI765262B (zh) * | 2019-06-26 | 2022-05-21 | 長佳智能股份有限公司 | 根據仿真分離重疊染色體之分離模型的訓練方法及利用該分離模型分離重疊染色體的方法及系統 |
US20220290245A1 (en) * | 2019-09-11 | 2022-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Cancer detection and classification |
CA3151538A1 (en) | 2019-09-30 | 2021-04-08 | Stefanie Ann Ward Mortimer | Compositions and methods for analyzing cell-free dna in methylation partitioning assays |
US11795495B1 (en) * | 2019-10-02 | 2023-10-24 | FOXO Labs Inc. | Machine learned epigenetic status estimator |
WO2021096932A1 (en) * | 2019-11-13 | 2021-05-20 | Memorial Sloan Kettering Cancer Center | Classifier models to predict tissue of origin from targeted tumor dna sequencing |
CN110867254A (zh) * | 2019-11-18 | 2020-03-06 | 北京市商汤科技开发有限公司 | 预测方法及装置、电子设备和存储介质 |
US20230049979A1 (en) * | 2020-02-06 | 2023-02-16 | OncoHost Ltd. | Machine learning prediction of therapy response |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
CN112662765A (zh) * | 2020-03-17 | 2021-04-16 | 博尔诚(北京)科技有限公司 | 一种检测6种中国高发癌症的探针组合物 |
CN111334572B (zh) * | 2020-04-26 | 2020-10-27 | 江苏大学附属医院 | Ctsz基因甲基化的新用途 |
US20230212684A1 (en) * | 2020-05-05 | 2023-07-06 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free dna biomarkers and their use in diagnosis, monitoring response to therapy, and selection of therapy for prostate cancer |
CN113234825A (zh) * | 2020-05-09 | 2021-08-10 | 广州燃石医学检验所有限公司 | 癌症预后方法 |
CN112391466A (zh) * | 2020-05-19 | 2021-02-23 | 广州市基准医疗有限责任公司 | 用于检测乳腺癌的甲基化生物标记物或其组合和应用 |
CN111863138A (zh) * | 2020-05-26 | 2020-10-30 | 浙江大学 | 人子宫组织细胞组成分析模型及其建立方法和应用 |
US11255762B1 (en) * | 2020-08-11 | 2022-02-22 | Specialty Diagnostic (SDI) Laboratories, Inc. | Method and system for classifying sample data for robotically extracted samples |
KR102461582B1 (ko) * | 2020-08-11 | 2022-10-31 | 한림대학교 산학협력단 | 인공지능을 활용하여 검진 정보에 대응하는 진단 정보를 제공하기 위한 컴퓨터 프로그램 |
AU2021329899A1 (en) * | 2020-08-19 | 2023-03-09 | Exact Sciences Corporation | Detecting non-hodgkin lymphoma |
CA3194028A1 (en) * | 2020-09-04 | 2022-03-10 | Cardio Diagnostics, Inc. | Methods and compositions for predicting and/or monitoring cardiovascular disease and treatments therefor |
US20230348997A1 (en) * | 2020-09-17 | 2023-11-02 | The Regents Of The University Of Colorado, A Body Corporate | Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions |
CN116917474A (zh) * | 2020-11-13 | 2023-10-20 | 特里普巴尔生物公司 | 多参数发现和优化平台 |
KR102507489B1 (ko) * | 2020-12-24 | 2023-03-08 | 가톨릭대학교 산학협력단 | 진단 분류 장치 및 방법 |
CN113095376A (zh) * | 2021-03-24 | 2021-07-09 | 四川大学 | 一种基于深度学习的口腔上皮异常增生判别与分级设备及系统 |
US20240194295A1 (en) * | 2021-04-21 | 2024-06-13 | Helio Health Inc. | Cellular heterogeneity-adjusted clonal methylation (chalm): a methylation quantification method |
CN113376199A (zh) * | 2021-05-12 | 2021-09-10 | 兰立生物科技(苏州)有限公司 | 一种用于癌症检测的生化分析检测系统 |
JP2024519082A (ja) | 2021-05-21 | 2024-05-08 | オフィオミクス-インベスティガカオ イー デセンボルヴィメント エン バイオテクノロジア エスエー | 肝細胞がんのdnaメチル化バイオマーカー |
WO2023287953A1 (en) * | 2021-07-14 | 2023-01-19 | The Regents Of The University Of California | Mycobiome in cancer |
EP4376022A1 (en) * | 2021-07-23 | 2024-05-29 | Kaohsiung Medical University | Clinical therapeutic drug prediction and recommendation system and method for evaluating efficacy of second-generation hormone drug in treatment of prostate cancer |
WO2023017525A1 (en) | 2021-08-11 | 2023-02-16 | OncoHost Ltd. | Predicting patient response |
WO2023031485A1 (en) | 2021-09-06 | 2023-03-09 | Christian-Albrechts-Universität Zu Kiel | Method for the diagnosis and/or classification of a disease in a subject |
CN118215845A (zh) | 2021-09-13 | 2024-06-18 | 普罗科技有限公司 | 增强的对生物分子的检测和定量 |
CN117957331A (zh) * | 2021-10-15 | 2024-04-30 | 富士胶片株式会社 | 用于癌检测的生物标志物组的制作方法 |
CN114003752B (zh) * | 2021-11-24 | 2022-11-15 | 重庆邮电大学 | 基于粒球人脸聚类图像质量评估的数据库精简方法及系统 |
KR20230085834A (ko) | 2021-12-07 | 2023-06-14 | 한양대학교 에리카산학협력단 | 필터와 다중 진입점 구조를 이용한 캐싱 방법 및 장치 |
CN114657247B (zh) * | 2022-02-28 | 2022-12-02 | 北京莱盟君泰国际医疗技术开发有限公司 | 用于早期肝癌检测的dna甲基化生物标记物或组合及其应用 |
US20240021267A1 (en) * | 2022-07-18 | 2024-01-18 | Grail, Llc | Dynamically selecting sequencing subregions for cancer classification |
WO2024025831A1 (en) * | 2022-07-25 | 2024-02-01 | Grail, Llc | Sample contamination detection of contaminated fragments with cpg-snp contamination markers |
CN115627541B (zh) * | 2022-12-01 | 2023-03-28 | 中国医学科学院肿瘤医院 | 从微量DNA建立cfDNA库的方法、系统和应用 |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5525462A (en) | 1991-05-02 | 1996-06-11 | Toyo Boseki Kabushiki Kaisha | Nucleic acid sequence amplification method, detection method, and reagent kit therefor |
US6033854A (en) | 1991-12-16 | 2000-03-07 | Biotronics Corporation | Quantitative PCR using blocking oligonucleotides |
WO1995006137A1 (en) | 1993-08-27 | 1995-03-02 | Australian Red Cross Society | Detection of genes |
US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
GB9517955D0 (en) | 1995-07-25 | 1995-11-08 | Univ Strathclyde | Nucleotide sequence detection and analysis |
US5985557A (en) | 1996-01-24 | 1999-11-16 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
US6852487B1 (en) | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
CA2255774C (en) | 1996-05-29 | 2008-03-18 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
US6017704A (en) | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
US5858665A (en) | 1996-07-25 | 1999-01-12 | Navix, Inc. | Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification |
CA2268069A1 (en) | 1996-10-04 | 1998-04-09 | Chronix Biomedical | Diagnostic detection of nucleic acids |
JPH10253632A (ja) | 1997-03-10 | 1998-09-25 | Nissui Pharm Co Ltd | 分析方法、キット及び装置 |
US6558901B1 (en) | 1997-05-02 | 2003-05-06 | Biomerieux Vitek | Nucleic acid assays |
US6054276A (en) | 1998-02-23 | 2000-04-25 | Macevicz; Stephen C. | DNA restriction site mapping |
US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
WO1999057321A1 (en) | 1998-05-01 | 1999-11-11 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
US7700324B1 (en) | 1998-11-03 | 2010-04-20 | The Johns Hopkins University School Of Medicine | Methylated CpG island amplification (MCA) |
US6331393B1 (en) | 1999-05-14 | 2001-12-18 | University Of Southern California | Process for high-throughput DNA methylation analysis |
US6180349B1 (en) | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
US7611869B2 (en) | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
DE10130800B4 (de) | 2001-06-22 | 2005-06-23 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität |
EP1470255A2 (en) | 2002-01-30 | 2004-10-27 | Epigenomics AG | Identification of cell differentiation states based on methylation patterns |
CA2489360C (en) | 2002-06-26 | 2013-01-29 | Cold Spring Harbor Laboratory | Methods and compositions for determining methylation profiles |
DE602004019941D1 (de) | 2003-07-31 | 2009-04-23 | Sequenom Inc | Verfahren für multiplex-polymerasekettenreaktionen auf hohem niveau und homogenen massenverlängerungsreaktionen zur genotypisierung von polymorphismen |
US20060183128A1 (en) | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
US7901880B2 (en) | 2003-10-21 | 2011-03-08 | Orion Genomics Llc | Differential enzymatic fragmentation |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
ES2801379T3 (es) * | 2003-12-01 | 2021-01-11 | Epigenomics Ag | Métodos y ácidos nucleicos para el análisis de la expresión génica asociada con el desarrollo de trastornos proliferativos de células de próstata |
WO2005085477A1 (en) | 2004-03-02 | 2005-09-15 | Orion Genomics Llc | Differential enzymatic fragmentation by whole genome amplification |
JP2005328709A (ja) | 2004-05-18 | 2005-12-02 | Toyobo Co Ltd | 高速dnaポリメラーゼを用いた高速pcr |
US20080171318A1 (en) * | 2004-09-30 | 2008-07-17 | Epigenomics Ag | Epigenetic Methods and Nucleic Acids for the Detection of Lung Cell Proliferative Disorders |
US7643818B2 (en) | 2004-11-22 | 2010-01-05 | Seven Networks, Inc. | E-mail messaging to/from a mobile terminal |
WO2006056480A2 (en) | 2004-11-29 | 2006-06-01 | Klinikum Der Universität Regensburg | Means and methods for detecting methylated dna |
US20080261217A1 (en) * | 2006-10-17 | 2008-10-23 | Melnikov Anatoliy A | Methylation Profile of Cancer |
GB0700374D0 (en) | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
US20090170087A1 (en) * | 2007-02-02 | 2009-07-02 | Orion Genomics Llc | Gene Methylation in Cervical Cancer Diagnosis |
US8911937B2 (en) | 2007-07-19 | 2014-12-16 | Brainreader Aps | Method for detecting methylation status by using methylation-independent primers |
WO2009021141A1 (en) | 2007-08-07 | 2009-02-12 | The Johns Hopkins University | Comprehensive high throughput arrays for relative methylation |
EP2053131A1 (en) | 2007-10-19 | 2009-04-29 | Ludwig-Maximilians-Universität München | Method for determining methylation at deoxycytosine residues |
US9850540B2 (en) * | 2008-03-14 | 2017-12-26 | Genomictree, Inc. | Method for detecting lung cancer using lung cancer-specific methylation marker gene |
WO2012031329A1 (en) | 2010-09-10 | 2012-03-15 | Murdoch Childrens Research Institute | Assay for detection and monitoring of cancer |
WO2012098215A1 (en) | 2011-01-20 | 2012-07-26 | Université Libre de Bruxelles | Epigenetic portraits of human breast cancers |
GB201102014D0 (en) | 2011-02-04 | 2011-03-23 | Ucl Business Plc | Method for predicting risk of developing cancer |
WO2012138609A2 (en) * | 2011-04-04 | 2012-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methylation biomarkers for diagnosis of prostate cancer |
WO2012149171A1 (en) | 2011-04-27 | 2012-11-01 | The Regents Of The University Of California | Designing padlock probes for targeted genomic sequencing |
US20130084286A1 (en) | 2011-08-31 | 2013-04-04 | Thomas E. Januario | Diagnostic markers |
US8846316B2 (en) | 2012-04-30 | 2014-09-30 | Industrial Technology Research Institute | Biomarker for human liver cancer |
AU2012380717B2 (en) * | 2012-05-24 | 2018-08-16 | Fundacio Institucio Catalana De Recerca I Estudis Avancats | Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis |
JP6269493B2 (ja) * | 2012-09-19 | 2018-01-31 | シスメックス株式会社 | 脳腫瘍に関する情報の取得方法、ならびに脳腫瘍に関する情報を取得するためのマーカーおよびキット |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
US20140271455A1 (en) * | 2013-03-14 | 2014-09-18 | City Of Hope | Dna methylation biomarkers for small cell lung cancer |
US9984201B2 (en) | 2015-01-18 | 2018-05-29 | Youhealth Biotech, Limited | Method and system for determining cancer status |
-
2015
- 2015-12-31 US US14/986,520 patent/US9984201B2/en active Active
-
2016
- 2016-01-15 CN CN201680004125.9A patent/CN108064314B/zh active Active
- 2016-01-15 EA EA201791569A patent/EA036566B1/ru unknown
- 2016-01-15 KR KR1020177022935A patent/KR20170120595A/ko not_active Application Discontinuation
- 2016-01-15 EP EP16738013.8A patent/EP3245604B1/en active Active
- 2016-01-15 SG SG11201705878VA patent/SG11201705878VA/en unknown
- 2016-01-15 SG SG10202010694PA patent/SG10202010694PA/en unknown
- 2016-01-15 WO PCT/US2016/013716 patent/WO2016115530A1/en active Application Filing
- 2016-01-15 BR BR112017015413-7A patent/BR112017015413A2/pt active Search and Examination
- 2016-01-15 CN CN202110186616.2A patent/CN113724786A/zh active Pending
- 2016-01-15 MX MX2017009351A patent/MX2017009351A/es unknown
- 2016-01-15 CA CA2974097A patent/CA2974097A1/en not_active Abandoned
- 2016-01-15 JP JP2017556781A patent/JP2018508228A/ja active Pending
- 2016-01-15 AU AU2016206505A patent/AU2016206505B2/en active Active
- 2016-01-18 TW TW105101456A patent/TW201638815A/zh unknown
- 2016-01-18 TW TW108114775A patent/TW202011416A/zh unknown
-
2017
- 2017-07-18 IL IL253546A patent/IL253546A0/en unknown
-
2018
- 2018-01-08 US US15/865,152 patent/US20180341745A1/en active Pending
- 2018-06-19 HK HK18107857.7A patent/HK1248285A1/zh unknown
-
2020
- 2020-07-29 JP JP2020128392A patent/JP2021003108A/ja active Pending
-
2022
- 2022-02-18 JP JP2022024038A patent/JP2022078120A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021003108A (ja) | 2021-01-14 |
CN113724786A (zh) | 2021-11-30 |
EP3245604A1 (en) | 2017-11-22 |
TW202011416A (zh) | 2020-03-16 |
EA201791569A1 (ru) | 2018-01-31 |
HK1248285A1 (zh) | 2018-10-12 |
US20180341745A1 (en) | 2018-11-29 |
US20160210403A1 (en) | 2016-07-21 |
SG10202010694PA (en) | 2020-12-30 |
SG11201705878VA (en) | 2017-08-30 |
CA2974097A1 (en) | 2016-07-21 |
TW201638815A (zh) | 2016-11-01 |
EP3245604B1 (en) | 2022-03-02 |
CN108064314B (zh) | 2021-03-09 |
AU2016206505A1 (en) | 2017-08-31 |
EP3245604A4 (en) | 2018-06-20 |
EA036566B1 (ru) | 2020-11-24 |
WO2016115530A1 (en) | 2016-07-21 |
CN108064314A (zh) | 2018-05-22 |
AU2016206505B2 (en) | 2022-03-10 |
JP2022078120A (ja) | 2022-05-24 |
IL253546A0 (en) | 2017-09-28 |
KR20170120595A (ko) | 2017-10-31 |
BR112017015413A2 (pt) | 2018-08-07 |
JP2018508228A (ja) | 2018-03-29 |
US9984201B2 (en) | 2018-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017009351A (es) | Metodo y sistema para determinar el estado de cancer. | |
IL270887A (en) | Systems and methods for creating, imaging and classifying molecular functional profiles | |
ZA201903517B (en) | Methods and systems for identity creation, verification and management | |
EP3499795A4 (en) | AUTHENTICATION SYSTEM AND METHOD, AND USER EQUIPMENT, AUTHENTICATION SERVER, AND SERVICE SERVER FOR EXECUTING SAID METHOD | |
EP3350961A4 (en) | Computer-implemented cryptographic method for improving a computer network, and terminal, system and computer-readable medium for the same | |
EP3248310A4 (en) | Method, apparatus, and system for quantum key distribution | |
TW201714434A (en) | Network initiated packet data network connection | |
EP3139331A4 (en) | Advertisement template configuration method, server and system | |
EP3116177A4 (en) | Service implementation method for nfv system, and communications unit | |
EP3732824A4 (en) | METHODS AND SYSTEMS FOR NETWORK MICROSEGMENTATION BASED ON CRYPTOGRAPHIC IDENTITY | |
EP3349129A4 (en) | Region division method in distributed database, region node and system | |
EP3425938A4 (en) | INVOICING SYSTEM AND METHOD, AND NETWORK DEVICE | |
EP3422760A4 (en) | Channel information reporting method, apparatus and system | |
EP3370366A4 (en) | Method, apparatus, and system for providing temporary account information | |
PL3378213T3 (pl) | Systemy i sposoby uwierzytelniania komunikatów sieciowych | |
ZA201905019B (en) | Beam selection method, apparatus and system | |
MX2019012352A (es) | Composiciones, sistemas, kits y metodos para ablacion neural. | |
EP3244667A4 (en) | Call supplementary service configuration synchronization method, apparatus and system | |
HK1256337A1 (zh) | 信息通信系統、信息通信程序以及信息通信方法 | |
MX2017009180A (es) | Biomateriales de nanocelulosa sintetizada bacterialmente y de fases múltiples, y método para producirlos. | |
EP3432543A4 (en) | SYSTEM AND METHOD FOR PROVIDING SERVICE, SERVICE RECEPTION / DISTRIBUTION SYSTEM, AND PROGRAM | |
EP3373148A4 (en) | DATABASE SYSTEM, TRANSACTION MANAGEMENT NODES, PROCEDURES AND PROGRAM | |
HK1212528A1 (en) | Information push method, terminal and system | |
GB201706804D0 (en) | ALM base plate, system and method | |
EP3438838A4 (en) | SERVICE DELIVERY SYSTEM, SERVICE PACKING SYSTEM, SERVICE PROCESSING AND PROGRAM |